You are here

Home

Clinical Trials: Musculoskeletal Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, October 18, 2021 - 12:00
Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases
Condition:   Osteoarthritis of Knee
Interventions:   Drug: MesoCellA-Ortho administration;   Drug: HA administration
Sponsors:   Jagiellonian University;   National Center for Research and Development, Poland;   KCRI
Not yet recruiting
Posted: Monday, October 4, 2021 - 12:00
Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD
Conditions:   Intervertebral Disc Degeneration;   Chronic Low-back Pain
Interventions:   Drug: Autologous BM-MSC;   Procedure: Sham
Sponsors:   Campus Bio-Medico University;   Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico;   Center for Outcomes Research and Clinical Epidemiology, Italy
Recruiting
Posted: Friday, October 1, 2021 - 12:00
MABs Therapy m.3243A>G Mutation Carriers
Condition:   Mitochondrial Myopathies
Intervention:   Biological: autologous mesoangioblasts
Sponsor:   Maastricht University
Recruiting
Posted: Thursday, September 2, 2021 - 12:00
Cell Therapy for IBM by Muscle Injection of ADSVF: a Phase I Trial
Condition:   Inclusion Body Myositis
Intervention:   Biological: ADSVF
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Posted: Monday, August 30, 2021 - 12:00
Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)
Condition:   Osteoarthritis, Knee
Interventions:   Drug: Bone marrow mesenchymal stem cells;   Drug: hyaluronic acid
Sponsors:   Taiwan Bio Therapeutics Co., Ltd.;   A2 Healthcare Taiwan Corporation
Not yet recruiting
Posted: Monday, August 23, 2021 - 12:00
Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury
Condition:   Osteoarthritis, Knee
Interventions:   Biological: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs);   Procedure: Marrow cellution
Sponsors:   Cytopeutics Sdn. Bhd.;   Universiti Kebangsaan Malaysia Medical Centre
Recruiting
Posted: Wednesday, August 11, 2021 - 12:00
Clinical Study of Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Knee Osteoarthritis
Condition:   Knee Osteoarthritis
Interventions:   Other: normal saline;   Other: Cord Blood Mononuclear Cells (UCB-MNCs)
Sponsor:   Lili Cao
Recruiting
Posted: Tuesday, August 10, 2021 - 12:00
Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules as Enhancers of Bone Formation in Bone Grafting
Conditions:   Bone Loss, Osteoclastic;   Bone Loss, Alveolar;   Alveolar Bone Loss;   Alveolar Bone Atrophy;   Grafting Bone
Intervention:   Procedure: Maxillary sinus floor elevation grafting with synthetic bone substitute.
Sponsors:   Pontificia Universidade Católica do Rio Grande do Sul;   ITI International Team for Implantology, Switzerland;   KU Leuven;   Rio Grande do Sul Brain Institute (InsCer)
Not yet recruiting
Posted: Wednesday, August 4, 2021 - 12:00
Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip Osteoarthritis
Condition:   Hip Osteoarthritis
Interventions:   Combination Product: Emcyte PureBMC;   Drug: Triamcinolone
Sponsors:   The Cleveland Clinic;   Lisa Dean Moseley Foundation
Not yet recruiting
Posted: Monday, July 26, 2021 - 12:00
Evaluate the Safety, Tolerability and Efficacy of PN-101 in Patients With Refractory Polymyositis or Dermatomyositis
Conditions:   Polymyositis;   Dermatomyositis
Intervention:   Biological: PN-101
Sponsor:   Paean Biotechnology Inc.
Not yet recruiting

Pages